KINGDON CAPITAL MANAGEMENT, L.L.C. - KEMPHARM INC ownership

KEMPHARM INC's ticker is and the CUSIP is 488445AB3. A total of 4 filers reported holding KEMPHARM INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
KINGDON CAPITAL MANAGEMENT, L.L.C. ownership history of KEMPHARM INC
ValueSharesWeighting
Q4 2019$1,230,000
-2.6%
3,000,0000.0%0.18%
+24.2%
Q3 2019$1,263,000
-9.5%
3,000,0000.0%0.15%
+8.8%
Q2 2019$1,395,000
-6.8%
3,000,0000.0%0.14%
-31.5%
Q1 2019$1,496,000
-0.9%
3,000,0000.0%0.20%
-12.3%
Q4 2018$1,509,000
-15.7%
3,000,0000.0%0.23%
+82.4%
Q3 2018$1,789,000
-10.8%
3,000,0000.0%0.12%
-10.7%
Q2 2018$2,005,000
-2.9%
3,000,0000.0%0.14%
-14.1%
Q1 2018$2,065,000
+11.6%
3,000,0000.0%0.16%
+37.0%
Q4 2017$1,851,000
+1.4%
3,000,0000.0%0.12%0.0%
Q3 2017$1,826,000
-1.9%
3,000,0000.0%0.12%
-6.3%
Q2 2017$1,862,0003,000,0000.13%
Other shareholders
KEMPHARM INC shareholders Q3 2018
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 75,000,000$57,250,0001.98%
DSC Advisors, L.P. 8,250,000$6,112,0001.28%
KINGDON CAPITAL MANAGEMENT, L.L.C. 3,000,000$2,065,0000.16%
View complete list of KEMPHARM INC shareholders